Most of the claims I've read of a possible vaccine have seemed a bit flimsy on closer inspection. This one from The Guardian has given me optimism though. Or maybe I'm just desperate for some..
The head of the European Union executive has said a German company might have a vaccine against coronavirus by the autumn.
The European commission president, Ursula von der Leyen, released €80m (£71.7m) of EU funds to the German pharmaceutical company CureVac on Monday, after discussing with executives their vaccine plans. She said:
"They are working on a patent that has already been approved and gone through the specific processes that are necessary, so they are highly specialised in this field. And it is their prediction that they might be able towards fall to have a vaccine that is fighting coronavirus."
German media reported that Donald Trump had tried to buy the company over the weekend, although the firm has distanced itself from those claims.
Von der Leyen said: “It is a European company. We wanted to keep it in Europe, it wanted to stay in Europe.” She said rules on approval of medical products would speed up “as we are in a severe crisis we all see that we are able to speed up many of the processes that are slow normally and take a lot of time”.
The head of the European Union executive has said a German company might have a vaccine against coronavirus by the autumn.
The European commission president, Ursula von der Leyen, released €80m (£71.7m) of EU funds to the German pharmaceutical company CureVac on Monday, after discussing with executives their vaccine plans. She said:
"They are working on a patent that has already been approved and gone through the specific processes that are necessary, so they are highly specialised in this field. And it is their prediction that they might be able towards fall to have a vaccine that is fighting coronavirus."
German media reported that Donald Trump had tried to buy the company over the weekend, although the firm has distanced itself from those claims.
Von der Leyen said: “It is a European company. We wanted to keep it in Europe, it wanted to stay in Europe.” She said rules on approval of medical products would speed up “as we are in a severe crisis we all see that we are able to speed up many of the processes that are slow normally and take a lot of time”.